Danmörk - danska - SEGES Landbrug & Fødevarer

cyanamid danmark a/s - triazamat, alfa-cypermethrin - flydende middel - 120 g/l triazamat; 38,4 g/l alpha-cypermethrin

Danmörk - danska - SEGES Landbrug & Fødevarer

basf a/s - triazamat - flydende middel - 140 g/l triazamat

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

pfizer aps - triazolam - tabletter - 0,125 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - triazolam - tabletter - 0,125 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - triazolam - tabletter - 0,125 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

pfizer aps - triazolam - tabletter - 0,25 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - triazolam - tabletter - 0,25 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - triazolam - tabletter - 0,25 mg

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - triazolam - tabletter - 0,25 mg

Evrópusambandið - danska - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infektioner - antivirale midler til systemisk anvendelse - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.